Metraipolis › archive › dc_ebff375ad279

Comparative Efficacy and Safety of Topical Clobetasol Propionate 0.05% Ointment Versus Topical Methotrexate 1% Gel in Limited Plaque Psoriasis: A Prospective… — Europe PMC PMID:42051836

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42051836
DOI: 10.7759/cureus.105980
License (as archived): solo-consultazione
Archived: 2026-11-03T19:42:07.434Z
SHA-256 of the archived text: b8e839572e95f3712a51da814e0696cc667309bb4ace3554be1bf1212f65d035
Stable URL of this page: https://metraipolis.com/documento/dc_ebff375ad279

How to cite

Comparative Efficacy and Safety of Topical Clobetasol Propionate 0.05% Ointment Versus Topical Methotrexate 1% Gel in Limited Plaque Psoriasis: A Prospective… — Europe PMC PMID:42051836 — Europe PMC (en), https://europepmc.org/article/MED/42051836 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebff375ad279 (Metraipolis archive dc_ebff375ad279, sha256 b8e839572e95f3712a51da814e0696cc667309bb4ace3554be1bf1212f65d035)

BibTeX

@misc{dcebff375ad279,
  title = {Comparative Efficacy and Safety of Topical Clobetasol Propionate 0.05% Ointment Versus Topical Methotrexate 1% Gel in Limited Plaque Psoriasis: A Prospective… — Europe PMC PMID:42051836},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42051836},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebff375ad279; sha256 b8e839572e95f3712a51da814e0696cc667309bb4ace3554be1bf1212f65d035},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42051836. Agents can read the archived copy with the MCP tool read_document.